CoChat
Sign Up
Cited by 201Dialysis and Renal Disease ManagementCholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Serum Amyloid A in Uremic HDL Promotes Inflammation

Open access
Weichhart, Thomas, Kopecky, Chantal, Kubicek, Markus, Haidinger, Michael, Döller, Dominik, Katholnig, Karl, Suarna, Cacang, Eller, Philipp, Tölle, Markus, Gerner, Christopher, Zlabinger, Gerhard J., van der Giet, Markus, Hörl, Walter H., Stocker, Roland, Säemann, Marcus D.·2012·Journal of the American Society of Nephrology
DOI 10.1681/asn.2011070668PMC PMC3338291
Open this paper in CoChat — free account

Abstract

Uremia impairs the atheroprotective properties of HDL, but the mechanisms underlying why this occurs are unknown. Here, we observed that HDL isolated from healthy individuals inhibited the production of inflammatory cytokines by peripheral monocytes stimulated with a Toll-like receptor 2 agonist. In contrast, HDL isolated from the majority of patients with ESRD did not show this anti-inflammatory property; many HDL samples even promoted the production of inflammatory cytokines. To investigate this difference, we used shotgun proteomics to identify 49 HDL-associated proteins in a uremia-specific pattern. Proteins enriched in HDL from patients with ESRD (ESRD-HDL) included surfactant protein B (SP-B), apolipoprotein C-II, serum amyloid A (SAA), and α-1-microglobulin/bikunin precursor. In addition, we detected some ESRD-enriched proteins in earlier stages of CKD. We did not detect a difference in oxidation status between HDL isolated from uremic and healthy patients. Regarding function of these uremia-specific proteins, only SAA mimicked ESRD-HDL by promoting inflammatory cytokine production. Furthermore, SAA levels in ESRD-HDL inversely correlated with its anti-inflammatory potency. In conclusion, HDL has anti-inflammatory activities that are defective in uremic patients as a result of specific changes in its molecular composition. These data suggest a potential link between the high levels of inflammation and cardiovascular mortality in uremia.

Overview

Integrity signals

Registry

Crossref · 10.1681/asn.2011070668

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

See all 201

Related

See all

Metadata

Authors
Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., Zlabinger, G. J., van der Giet, M., Hörl, W. H., Stocker, R., & Säemann, M. D.
Affiliations
  • Medical University of Vienna (AT)
  • The University of Sydney (AU)
  • Medical University of Graz (AT)
  • Charité – Universitätsmedizin Berlin (DE)
  • Comprehensive Cancer Center Vienna (AT)
Corresponding author
  • Weichhart, Thomas
  • Kopecky, Chantal
  • Haidinger, Michael
  • Döller, Dominik
  • Katholnig, Karl
  • Zlabinger, Gerhard J.
  • Hörl, Walter H.
  • Säemann, Marcus D.
ORCID
Venue
Journal of the American Society of Nephrology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2012-05
Volume
23
Issue
5
Pages
934-947
ISSN
1046-6673 (ISSN-L)
DOI
10.1681/asn.2011070668
PMC
PMC3338291
OpenAlex
W2139976637
Cited by
201
References
81
Citations by year
2026: 5 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 13 · 2021: 18 · 2020: 11 · 2019: 15 · 2018: 17 · 2017: 20 · 2016: 17 · 2015: 22 · 2014: 21 · 2013: 18 · 2012: 6
FWCI
16.92
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
serum amyloid A, end-stage renal disease, HDL dysfunction, inflammation, inflammatory cytokines, TLR2, monocytes, HDL-associated proteins, surfactant protein B, apolipoprotein C-II, alpha1-microglobulin, HDL oxidation, chronic kidney disease, cardiovascular mortality
MeSH terms
Adult, Aged, Serum Amyloid A Protein, Female, Humans, Inflammation, Iron, Kidney Failure, Chronic, Lipoproteins, HDL, Male, Middle Aged, Oxidation-Reduction, Uremia, Pulmonary Surfactant-Associated Protein B, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review